Various coarse-grained (CG) models have become increasingly common in studies of antibody-antibody interactions in solution. These models appear poised to enter development pipelines in the near future to help predict and understand how antibody-antibody interactions influence the suitability of a given monoclonal antibody (mAb) for mass production and delivery as an antibody therapy. This blog post is a non-exhaustive summary of some of the highlights I found during a recent literature search.
Continue readingTag Archives: Simulation
Do you have cis peptide bonds in your simulation inputs?
People who run molecular simulations quickly become familiar with all of the things about a PDB file – missing residues, missing heavy atoms in residues, missing hydrogens, non-standard amino acids, multiple conformations, crystallization ligands, etc. – that might need to be fixed before setting up a simulation. This blog post is a reminder to check, after you have “fixed” your PDB, if you have accidentally introduced aberrant cis peptide bonds into your structure during rebuilding.
Continue reading